Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-Markers

More search options...

Apple, FS; Collinson, PO; Kavsak, PA; Body, R; Ordóñez-Llanos, J; Saenger, AK; Omland, T; Hammarsten, O; Jaffe, AS; IFCC Committee Clinical Application of Cardiac Biomarkers (2021) Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-Markers. Clin Chem, 67 (5). pp. 730-735. ISSN 1530-8561 https://doi.org/10.1093/clinchem/hvaa337
SGUL Authors: Collinson, Paul

Preview

PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].
Download (103kB) | Preview

Abstract

The Committee on the Clinical Application of Cardiac Biomarkers (C-CB) of the International Federation of Clinical Chemistry (IFCC) represents international groups from laboratory medicine, cardiology and emergency medicine involved in providing global educational guidance pertaining to the analytical and clinical applications of cardiac biomarkers. For that reason, most of the members are involved with national and international studies and trials pertaining to high sensitivity (hs) cardiac troponins I and T (cTnI and cTnT) (1-3). Although the recently published '2020 European Society of Cardiology (ESC) guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation' present some topics very well, the current special report was developed to delineate our specific concerns regarding the ESB guidance for the use of hs-cardiac troponin (hs-cTn) (4).

Item Type:

Article

Additional Information:

This is a pre-copyedited, author-produced version of an article accepted for publication in Clinical Chemistry following peer review. The version of record Fred S Apple, Paul O Collinson, Peter A Kavsak, Richard Body, Jordi Ordóñez-Llanos, Amy K Saenger, Torbjorn Omland, Ola Hammarsten, Allan S Jaffe, the IFCC Committee on Clinical Applications of Cardiac Bio-Markers, Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-Markers, Clinical Chemistry, Volume 67, Issue 5, May 2021, Pages 730–735 is available online at: https://doi.org/10.1093/clinchem/hvaa337

Keywords:

IFCC Committee Clinical Application of Cardiac Biomarkers, 1004 Medical Biotechnology, 1101 Medical Biochemistry and Metabolomics, 1103 Clinical Sciences, General Clinical Medicine

SGUL Research Institute / Research Centre:

Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)

Journal or Publication Title:

Clin Chem

ISSN:

1530-8561

Language:

eng

Dates: